Genetic evidence for a link between favorable adiposity and lower risk of type 2 diabetes, hypertension, and heart disease

Diabetes

Volumn 65, Issue 8, 2016, Pages 2448-2460

  Yaghootkar, Hanieh ^a   Lotta, Luca A ^b   Tyrrell, Jessica ^a   Smit, Roelof A J ^c   Jones, Sam E ^a   Donnelly, Louise ^d   Beaumont, Robin ^a   Campbell, Archie ^e   Tuke, Marcus A ^a   Hayward, Caroline ^f   Ruth, Katherine S ^a   Padmanabhan, Sandosh ^g   Jukema, J Wouter ^c,h   Palmer, Colin C ^d   Hattersley, Andrew ^a   Freathy, Rachel M ^a   Langenberg, Claudia ^b   Wareham, Nicholas J ^b   Wood, Andrew R ^a   Murray, Anna ^a   Weedon, Michael N ^a   Sattar, Naveed ⁱ   Pearson, Ewan ^d   Scott, Robert A ^b   Frayling, Timothy M ^a   more..

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF GLASGOW   (United Kingdom)

^h INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; BODY MASS; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FAT FREE MASS; FAT MASS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART DISEASE; HEART INFARCTION; HIP CIRCUMFERENCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADULT; AGED; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETICS; HEART DISEASES; MIDDLE AGED; ODDS RATIO; PHYSIOLOGY; RISK FACTOR;

ADIPOSITY; ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84974559213     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1671     Document Type: Article

References (23)

1. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:699-713
2. Ruderman NB, Schneider SH, Berchtold P. The "metabolically-obese," normal-weight individual. Am J Clin Nutr 1981;34:1617-1621
3. Virtue S, Vidal-Puig A: Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta 2010;1801: 338-349
4. Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest 2006;116:581-589
5. Weedon MN, Ellard S, Prindle MJ, et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet 2013;45:947-950
6. Fall T, Hägg S, Mägi R, et al.; European Network for Genetic and Genomic Epidemiology (ENGAGE) consortium. The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med 2013;10:e1001474
7. Nordestgaard BG, Palmer TM, Benn M, et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 2012;9:e1001212
8. Scott RA, Lagou V, Welch RP, et al.; DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012;44:991-1005
9. Kilpeläinen TO, Zillikens MC, Stančákova A, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011;43:753-760
10. Yaghootkar H, Scott RA, White CC, et al. Genetic evidence for a normalweight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes 2014;63:4369-4377
11. Scott RA, Fall T, Pasko D, et al.; RISC Study Group; EPIC-InterAct Consortium. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity. Diabetes 2014;63: 4378-4387
12. Locke AE, Kahali B, Berndt SI, et al.; Life Lines Cohort Study; ADIPOGen Consortium; AGEN-BMI Working Group; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GLGC; ICBP; MAGIC Investigators; MuTHER Consortium; MIGen Consortium; PAGE Consortium; ReproGen Consortium; GENIE Consortium; International Endogene Consortium. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015;518:197-206
13. Collins R. What makes UK Biobank special? Lancet 2012;379:1173-1174
14. Abraham G, Inouye M. Fast principal component analysis of large-scale genome-wide data. PLoS One 2014;9:e93766
15. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulindependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997;350: 1505-1510
16. Smith BH, Campbell A, Linksted P, et al. Cohort profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol 2013;42:689-700
17. Shepherd J, Blauw GJ, Murphy MB, et al.; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in Elderly Individuals at Risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360: 1623-1630
18. Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol 1999; 84:1192-1197
19. Bingham S, Riboli E. Diet and cancer-the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004;4:206-215
20. Shungin D, Winkler TW, Croteau-Chonka DC, et al.; ADIPOGen Consortium; CARDIOGRAMplusC4D Consortium; CKDGen Consortium; GEFOS Consortium; GENIE Consortium; GLGC; ICBP; International Endogene Consortium; Life Lines Cohort Study; MAGIC Investigators; MuTHER Consortium; PAGE Consortium; ReproGen Consortium. New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015;518:187-196
21. Barak Y, Nelson MC, Ong ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999;4:585-595
22. Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet 2007;3:e64
23. Tseng YH, Kriauciunas KM, Kokkotou E, Kahn CR. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 2004;24: 1918-1929